Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Spikevax“
Suchtreffer
Begriffe & Kennungen
Spikevax (previously COVID-19 Vaccine Moderna) · 4.5 · Spikevax (including variant formulations) can be concomitantly administered with influenza vaccines (standard
Eintrag öffnenSpikevax (previously COVID-19 Vaccine Moderna) · 4.5 · Spikevax (including variant formulations) can be concomitantly administered with influenza vaccines (standard
Eintrag öffnenSpikevax (previously COVID-19 Vaccine Moderna) · 4.5 · Spikevax (including variant formulations) can be concomitantly administered with influenza vaccines (standard
Eintrag öffnenSpikevax (previously COVID-19 Vaccine Moderna) · 4.6 Fertility, pregnancy and lactation · 1
Eintrag öffnenSpikevax (previously COVID-19 Vaccine Moderna) · 4.6 Fertility, pregnancy and lactation · 2
Eintrag öffnenSpikevax (previously COVID-19 Vaccine Moderna) · 4.6 Fertility, pregnancy and lactation · 3
Eintrag öffnenSpikevax (previously COVID-19 Vaccine Moderna) · 4.8 Undesirable effects · 1
Eintrag öffnenSpikevax (previously COVID-19 Vaccine Moderna) · 4.8 Undesirable effects · 2
Eintrag öffnenSpikevax (previously COVID-19 Vaccine Moderna) · 4.8 Undesirable effects · 3
Eintrag öffnenSpikevax (previously COVID-19 Vaccine Moderna) · 4.8 · 10 Description of selected adverse reactions
Eintrag öffnenSpikevax (previously COVID-19 Vaccine Moderna) · 4.8 · 32 The safety of Spikevax (original) was evaluated in a Phase 3 randomised, placebo-controlled, observer-blind
Eintrag öffnenSpikevax (previously COVID-19 Vaccine Moderna) · 4.8 · 33 A Phase 2/3 randomised, placebo-controlled, observer-blind study to evaluate the safety, tolerability, reac
Eintrag öffnenSpikevax (previously COVID-19 Vaccine Moderna) · 4.8 · 34 MedDRA system organ class Frequency Adverse reactions Not known Hypersensitivity
Eintrag öffnenSpikevax (previously COVID-19 Vaccine Moderna) · 4.8 · 35 Adults (booster dose) The safety, reactogenicity, and immunogenicity of a booster dose of Spikevax (origina
Eintrag öffnenSpikevax (previously COVID-19 Vaccine Moderna) · 4.8 · 36 Description of selected adverse reactions
Eintrag öffnenSpikevax (previously COVID-19 Vaccine Moderna) · 4.8 · 57 The safety of Spikevax (original) was evaluated in a Phase 3 randomised, placebo-controlled, observer-blind
Eintrag öffnenSpikevax (previously COVID-19 Vaccine Moderna) · 4.8 · 58 A Phase 2/3 randomised, placebo-controlled, observer-blind study to evaluate the safety, tolerability, reac
Eintrag öffnenSpikevax (previously COVID-19 Vaccine Moderna) · 4.8 · 59 MedDRA system organ class Frequency Adverse reactions Not known Hypersensitivity
Eintrag öffnenSpikevax (previously COVID-19 Vaccine Moderna) · 4.8 · 6 The safety of Spikevax (original) was evaluated in a Phase 3 randomised, placebo-controlled, observer-blind
Eintrag öffnenSpikevax (previously COVID-19 Vaccine Moderna) · 4.8 · 60 Adults (booster dose) The safety, reactogenicity, and immunogenicity of a booster dose of Spikevax (origina
Eintrag öffnen